BRIEF published on 11/14/2024 at 11:05, 6 days 23 hours ago Travelex Issuerco 2 Plc Reports Q3 2024 Financial Results London Stock Exchange Investor Relations Financial Announcement Travelex Issuerco 2 Plc Q3 2024 Results
PRESS RELEASE published on 11/14/2024 at 11:00, 6 days 23 hours ago Travelex Issuerco 2 Plc: 3rd Quarter Results Travelex Issuerco 2 Plc announces Q3 2024 Results. Access the results at http://www.rns-pdf.londonstockexchange.com/rns/2666M_1-2024-11-14.pdf London Stock Exchange Financial Performance Investor Relations Travelex Issuerco 2 Plc Q3 2024 Results
BRIEF published on 09/13/2024 at 09:05, 2 months 8 days ago Travelex Issuerco 2 Plc Reports Q2 2024 Results Investor Relations Stock Exchange EQS Group AG Q2 Results Travelex
PRESS RELEASE published on 09/13/2024 at 09:00, 2 months 8 days ago Results for Q2 2024 Travelex Issuerco 2 Plc announces Q2 2024 results. Access the report at http://www.rns-pdf.londonstockexchange.com/rns/0277E_1-2024-9-12.pdf London Stock Exchange Financial Report Travelex Issuerco 2 Plc Q2 2024 Results Investor Inquiries
BRIEF published on 05/15/2024 at 08:35, 6 months 6 days ago Travelex Issuerco 2 Plc Announces Q1 2024 Results London Stock Exchange Investor Relations Financial Report Q1 2024 Results Travelex
PRESS RELEASE published on 05/15/2024 at 08:30, 6 months 6 days ago 1st Quarter Results Travelex Issuerco 2 Plc announces Q1 2024 results. Find the details in the press release provided. Contact for investor queries: Victoria.Benis-Lonsdale@travelex.com London Stock Exchange Financial Report Travelex Issuerco 2 Plc Investor Queries Q1 2024 Results
PRESS RELEASE published on 02/08/2024 at 08:00, 9 months 13 days ago Results for Q4 2023 Travelex Issuerco 2 Plc announces Q4 2023 results. Access the report via the provided link. Contact Victoria.Benis-Lonsdale@travelex.com for investor queries London Stock Exchange Financial Report Travelex Issuerco 2 Plc Q4 Results Investor Queries
PRESS RELEASE published on 10/30/2023 at 14:45, 1 year ago Buy back new money notes & stapled ordinary shares
PRESS RELEASE published on 09/27/2023 at 20:20, 1 year 1 month ago Travelex Issuerco 2 Plc: Buy back new money notes and stapled shares
PRESS RELEASE published on 09/27/2023 at 11:45, 1 year 1 month ago Travelex Issuerco 2 Plc: FY2022 Audited Consolidated Financial Statements
Published on 11/21/2024 at 10:03, 55 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 58 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 58 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 23 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 33 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 27 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 53 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 55 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 57 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 57 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 4 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 37 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 13 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 13 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
